Syneos Health_rgb_r.jpg
Dr. David S. Wilkes Appointed to Syneos Health Board of Directors
June 16, 2021 07:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., June 16, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of David S....
Syneos Health_rgb_r.jpg
Syneos Health Launches “Lab to Life” Enterprise Partnership with Komodo Health
May 03, 2021 07:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced today it has expanded its relationship...
Syneos Health_rgb_r.jpg
Illingworth Research Group Recognized with Queen’s Award for Enterprise: International Trade 2021
April 30, 2021 05:05 ET | Syneos Health, Inc.
MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) -- The Illingworth Research Group, a Syneos Health® company, has been recognized with a 2021 Queen’s Award for Enterprise for International Trade....
Syneos Health_rgb_r.jpg
Syneos Health Reports First Quarter 2021 Results
April 29, 2021 06:16 ET | Syneos Health, Inc.
Highlights Revenue of $1,208.7 million for the three months ended March 31, 2021, representing a sequential increase of 6.0% compared to the three months ended December 31, 2020, and a...
Syneos Health_rgb_r.jpg
Syneos Health Announces Pricing of Secondary Offering of Common Stock
March 01, 2021 09:28 ET | Syneos Health, Inc.
MORRISVILLE, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health_rgb_r.jpg
Syneos Health Schedules Fourth Quarter and Full Year 2020 Earnings Call for Thursday, February 18, 2021
January 26, 2021 18:37 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year...
Syneos Health_rgb_r.jpg
Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021 16:15 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Syneos Health_rgb_r.jpg
Syneos Health Completes Acquisition of Synteract
December 10, 2020 08:59 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it has completed the...
Syneos Health_rgb_r.jpg
Syneos Health to Outline Value Creation Plan at 2020 Analyst and Investor Event
December 07, 2020 17:18 ET | Syneos Health, Inc.
Unique Product Development Model Delivers Accelerated Growth Presentation Begins at 9:00 A.M. ET on Tuesday, December 8 MORRISVILLE, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Syneos Health®...
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research
December 03, 2020 08:49 ET | Syneos Health, Inc.
BOSTON and MORRISVILLE, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization and ConcertAI, the leader in oncology...